Oxybutynin (Compound)

Synonyms:oxybutynin, 5633-20-5, Ditropan, Oxytrol, Oxibutyninum, Oxybutyninum, Oxybutynine, Oxibutinina, Oxybutynine [INN-French], Oxybutyninum [INN-Latin], Oxybutinin, Oxibutinina [INN-Spanish], (RS)-oxybutynin, 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat, Ditropan Xl, Oxybutynin (Ditropan), 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate, 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate, 4-(diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, CHEMBL1231, CHEBI:7856, 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester, 5633-20-5 (free), Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester, MFCD00865252, Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester, kentera, Cystrin, 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate, Oxybutynin Base, Anturol, transdermal patch, Lyrinel XL, Oxytrol for Women, Oxybutynin [USAN:INN:BAN], CCRIS 1923, Oxybutynin transdermal, oxybutynin topical gel, HSDB 3270, Oxybutynin transdermal patch, Anturol (TN), Oxytrol (TN), Oxybutynin (USAN/INN), Prestwick0_000287, Prestwick1_000287, Prestwick2_000287, Prestwick3_000287, SCHEMBL2992, Lopac0_000923, BSPBio_000194, GTPL359, MLS006010052, SPBio_002413, BPBio1_000214, DTXSID0023406, OXYBUTYNIN, Oxybutynin chloride, CHEBI:144551, HMS3884K08, BCP12179, HY-B0267, AB7701, BDBM50165019, s1754, AKOS015896242, Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester, AC-2153, CCG-205005, DB01062, KS-5221, MCULE-3407007074, SDCCGSBI-0050898.P003, MRF-0000601, (+/-)-OXYBUTYNIN(Hydrochloride form), NCGC00015767-03, NCGC00015767-04, NCGC00015767-06, NCGC00015767-07, NCGC00015767-09, NCGC00015767-10, NCGC00015767-21, NCGC00089795-02, O222, SMR001550466, SBI-0050898.P002, AB0013281, FT-0603679, SW196787-3, C07360, D00465, 27815-EP2269989A1, 27815-EP2275420A1, 27815-EP2280008A2, 27815-EP2298767A1, 27815-EP2314587A1, 633O205, A831004, L000923, Q1060922, BRD-A65013509-003-03-8, BRD-A65013509-003-13-7

Pubchem:PUBCHEM:4634

Id:4634

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Oxybutynin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Oxybutynin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Oxybutynin.

Results found

Linked to

	Label	Description
	BRD-A65013509-003-13-7 Substance (Entity type)	A Substance
	DCSTRUCT ID 02028 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02028; PubChem_CID:4634, FILE=drugcentral_drug_02028.json)
	oxybutynin (1e61a376-23f6-4089-a748-1e4a7655f7c4) Collection (Entity type)	Metadatata for oxybutynin
	Oxybutynin positively regulates MAP7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tolcapone in similarity relationship with Oxybutynin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxybutynin bioactivity Sigma non-opioid intracellular receptor 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Oxybutynin negatively regulates IFI27 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxybutynin negatively regulates LAP3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxybutynin negatively regulates COQ8A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxybutynin positively regulates PXDN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS